JAGDEEP BAL: Open Payments
NPI 1548252703 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 22 payments from 14 companies in 2025. Trend: 2023 $512 · 2024 $567 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Indivior Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $41 |
| Dexcom, Inc. | 2 | $38 |
| Hologic Sales and Service, LLC | 2 | $35 |
| ALK-Abello, Inc | 1 | $28 |
| SANOFI PASTEUR INC. | 1 | $24 |
| Biocon Biologics Inc | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
Products named: TREMFYA, Kerendia, SUBLOCADE, Dexcom G6 Transmitter, APTIMA, Grastek, Rybelsus, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE.
Industry payments across CA — which companies pay providers there.
